Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nutra Pharma Corp. (NPHC) had Revenue of $0.11M for the most recently reported fiscal quarter, ending 2022-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2022-09-30

Income Statement Financials
Revenue	$0.11M
Net Income	$0.58M
Cost of Goods Sold	$0.04M
Gross Profit	$0.07M
Operating Expenses	$0.35M
Operating Income	$-0.24M
Non-Operating Income/Expense	$0.81M
Pre-Tax Income	$0.58M
Normalized Pre-Tax Income	$0.58M
Income after Taxes	$0.58M
Income from Continuous Operations	$0.58M
Consolidated Net Income/Loss	$0.58M
Normalized Income after Taxes	$0.58M
EBIT	$-0.24M
EBITDA	$-0.08M
Weighted-Average Shares Outstanding (Basic)	7.59B
Weighted-Average Shares Outstanding (Diluted)	15.60B
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$0.46M
Property, Plant, and Equipment	$0.09M
Long-Term Assets	$0.23M
Total Assets	$0.69M
Current Liabilities	$16.15M
Long-Term Debt	$0.15M
Long-Term Liabilities	$0.15M
Total Liabilities	$16.30M
Common Equity	$-15.62M
Tangible Shareholders Equity	$-15.61M
Shareholders Equity	$-15.61M
Common Shares Outstanding	7.60B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.71M
Cash Flow from Investing Activities	$-0.02M
Cash Flow from Financial Activities	$0.64M
Beginning Cash	$0.09M
End Cash	--
Increase/Decrease in Cash	$-0.09M
Stock-Based Compensation	$0.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.03
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.01
Debt to Equity Ratio	-0.51
Gross Margin	62.41%
Operating Margin	-216.59%
EBIT Margin	-216.59%
EBITDA Margin	--
Pre-Tax Profit Margin	528.58%
Profit Margin	528.58%
Free Cash Flow	$-0.77M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.83
Receiveable Turnover	0.37
Days Sales in Receivables	243.52
Return on Equity	-3.70%
Return on Tangible Equity	-3.70%
Return on Assets	83.58%
Return on Investments	-3.73%
Book Value Per Share	$-0.00
Free Cash Flow per Share	$0.00
Operating Cash Flow per Share	$0.00

Data from Zacks Investment Research, Inc.